Maturity-onset diabetes of the young type 2

Monogenic diabetes caused by inactivating mutation(s) in the GCK gene, encoding glucokinase. Heterozygous GCK mutations may manifest as mild hyperglycemia, which is not progressive, and usually requires no treatment. Homozygous GCK mutations result in permanent neonatal diabetes.

Also known as: GCK maturity-onset diabetes of the young (disease), GCK-associated diabetes mellitus, MODY 2 monogenic diabetes type 2, MODY, type II, MODY2, glucokinase-associated diabetes mellitus, maturity onset diabetes of the Young, type 2, maturity-onset diabetes of the young (disease) caused by mutation in GCK

39 clinical trials for this condition and its sub-types, 4 tagged with Maturity-onset diabetes of the young type 2 itself.